AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22587997 — intervention group
Group type: COMPARATOR
Intervention: Daily recombinant FSH (rFSH)
Number of subjects: 677
Study 22587997 — intervention group
Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (overall assessment)
Number of subjects: 677
Study 20546366 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized intervention for hospital discharge and follow-up planning
Number of subjects: 0
Study 20546366 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study 17954800 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-based solution (0.25% chlorhexidine gluconate, 0.025% benzalkonium chloride, and 4% benzylic alcohol)
Number of subjects: 538
Study 17954800 — intervention group
Group type: COMPARATOR
Intervention: Povidone-iodine (5% povidone-iodine in 70% ethanol)
Number of subjects: 538
Study 15812409 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin glue
Number of subjects: 0
Study 15812409 — intervention group
Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 0
Study 11956391 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical stabilization with Judet struts (S group)
Number of subjects: 37
Study 9793697 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine and TTH with psychiatric comorbidity (P-Co)
Number of subjects: 100
Study 9793697 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of psychiatric comorbidity (P-Co) in 1988
Number of subjects: 100
Study 9793697 — intervention group
Group type: EXPERIMENTAL
Intervention: Headache-free subjects in 1996
Number of subjects: 100
Study 9793697 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety disorders in 1988
Number of subjects: 100
Study 9793697 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 100
Study 9613336 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder Disability Questionnaire (SDQ)
Number of subjects: 349
Study 9613336 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain Severity Scale (PSS)
Number of subjects: 349
Study 9613336 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Status Questionnaire (FSQ)
Number of subjects: 349
Study 1927943 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous use of transdermal nitroglycerin (10 mg/24 hours)
Number of subjects: 127
Study 1927943 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent use of transdermal nitroglycerin (10 mg/24 hours)
Number of subjects: 127
Study 1927943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 1927943 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including placebo)
Number of subjects: 127
Study 1927943 — intervention group
Group type: EXPERIMENTAL
Intervention: All actively treated patients
Number of subjects: 127
Study 6356740 — intervention group
Group type: EXPERIMENTAL
Intervention: Gangliosides (20 mg daily i.m.)
Number of subjects: 140
Study 6356740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 30668157 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Low‐intensive Psychoeducational Intervention (CLI‐PEI)
Number of subjects: 43
Study 30668157 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual
Number of subjects: 43
Study 30593607 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI4166 50 mg
Number of subjects: 78
Study 30593607 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI4166 200 mg
Number of subjects: 78
Study 30593607 — intervention group
Group type: EXPERIMENTAL
Intervention: MEDI4166 400 mg
Number of subjects: 78
Study 30593607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 28051761 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-monitoring intervention
Number of subjects: 42
Study 26609704 — intervention group
Group type: EXPERIMENTAL
Intervention: SI-DMI (dance/movement intervention focusing on interpersonal movement imitation and synchronization)
Number of subjects: 55
Study 26609704 — intervention group
Group type: COMPARATOR
Intervention: CMI (control movement intervention focusing on individual motor coordination)
Number of subjects: 55
Study 26609704 — intervention group
Group type: EXPERIMENTAL
Intervention: SI-DMI
Number of subjects: 55
Study 26609704 — intervention group
Group type: COMPARATOR
Intervention: CMI
Number of subjects: 55
Study 26808856 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF) 6 mg·kg body mass
Number of subjects: 6
Study 26808856 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 6
Study 26808856 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 6
Study 24314193 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient lower esophageal sphincter relaxation (TLESR) mechanism
Number of subjects: 20
Study 24314193 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroesophageal function evaluation
Number of subjects: 20
Study 24314193 — intervention group
Group type: EXPERIMENTAL
Intervention: Impedance study
Number of subjects: 20
Study 24314193 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastric emptying evaluation
Number of subjects: 20
Study 21624734 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TIMP-4 concentration measured at baseline and 24 weeks
Number of subjects: 100
Study 21624734 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TIMP-1, TIMP-2, and TIMP-4 concentrations measured at baseline and 24 weeks
Number of subjects: 100
Study 21624734 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TIMP-4 concentration
Number of subjects: 100
Study 21624734 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma TIMP-2 concentration
Number of subjects: 100
Study 19699335 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day for 2 days
Number of subjects: 200
Study 19699335 — intervention group
Group type: COMPARATOR
Intervention: Control group (immediate PCI)
Number of subjects: 200
Study 16678497 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Laparoscopic Hysterectomy (TLH)
Number of subjects: 590
Study 16678497 — intervention group
Group type: COMPARATOR
Intervention: Total Abdominal Hysterectomy (TAH)
Number of subjects: 590
Study 15267214 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 280
Study 15267214 — intervention group
Group type: COMPARATOR
Intervention: Quinolone
Number of subjects: 280
Study 11673293 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsair 3000
Number of subjects: 150
Study 11673293 — intervention group
Group type: COMPARATOR
Intervention: Goldmann tonometry
Number of subjects: 150
Study 10069684 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg simvastatin (S)
Number of subjects: 64
Study 10069684 — intervention group
Group type: COMPARATOR
Intervention: 200 mg micronized fenofibrate (F)
Number of subjects: 64
Study 10069684 — intervention group
Group type: EXPERIMENTAL
Intervention: Both S and F
Number of subjects: 64
Study 7641018 — intervention group
Group type: EXPERIMENTAL
Intervention: Transanal abdominal transanal radical proctosigmoidectomy with coloanal anastomosis (TATA)
Number of subjects: 109
Study 7641018 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-thickness local excision (FTLE)
Number of subjects: 109
Study 2476978 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical retinoic acid treatment
Number of subjects: 0
Study 2476978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 755030 — intervention group
Group type: EXPERIMENTAL
Intervention: Amipaque
Number of subjects: 10
Study 755030 — intervention group
Group type: COMPARATOR
Intervention: Gastrografin
Number of subjects: 10
Study 31628677 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 300 mg
Number of subjects: 233
Study 31628677 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 233
Study 31628677 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab (both doses)
Number of subjects: 233
Study 31628677 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 233
Study 31733759 — intervention group
Group type: EXPERIMENTAL
Intervention: Core strengthening protocol (30-min sessions, twice a week for 5 consecutive weeks)
Number of subjects: 18
Study 31733759 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 18
Study 28104990 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin (100 mg daily)
Number of subjects: 12
Study 28104990 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI IDEAL technique
Number of subjects: 12
Study 26231437 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtotal hysterectomy
Number of subjects: 304
Study 26231437 — intervention group
Group type: COMPARATOR
Intervention: Total hysterectomy
Number of subjects: 304
Study 23521470 — intervention group
Group type: EXPERIMENTAL
Intervention: XPF caps
Number of subjects: 60
Study 23521470 — intervention group
Group type: EXPERIMENTAL
Intervention: XPF thyroid collars
Number of subjects: 60
Study 23521470 — intervention group
Group type: COMPARATOR
Intervention: Standard thyroid collars
Number of subjects: 60
Study 23521470 — intervention group
Group type: EXPERIMENTAL
Intervention: XPF caps and XPF thyroid collars
Number of subjects: 60
Study 21658524 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally responsive parent training (PT) program, 14-week intervention
Number of subjects: 54
Study 21658524 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (wait-list control)
Number of subjects: 54
Study 19200384 — intervention group
Group type: EXPERIMENTAL
Intervention: 11-month, nurse-delivered, telephone-based intervention
Number of subjects: 250
Study 19200384 — intervention group
Group type: COMPARATOR
Intervention: Printed education materials only
Number of subjects: 250
Study 16766855 — intervention group
Group type: EXPERIMENTAL
Intervention: Imidapril
Number of subjects: 29
Study 16766855 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 29
Study 15329302 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological assessment prior to smoking cessation treatment (including VSWM and WCST)
Number of subjects: 32
Study 15329302 — intervention group
Group type: COMPARATOR
Intervention: Non-psychiatric control smokers (n=40)
Number of subjects: 32
Study 11748103 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyroidism (H)
Number of subjects: 21
Study 11748103 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylcholine infusion in Hyperthyroidism (H)
Number of subjects: 21
Study 11748103 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine infusion in Hyperthyroidism (H)
Number of subjects: 21
Study 11748103 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA infusion in Hyperthyroidism (H)
Number of subjects: 21
Study 9029636 — intervention group
Group type: EXPERIMENTAL
Intervention: [U‐13C]18:3 omega 3
Number of subjects: 0
Study 9029636 — intervention group
Group type: EXPERIMENTAL
Intervention: [U‐13C]18:2 omega 6
Number of subjects: 0
Study 9662077 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 90 minutes
Number of subjects: 0
Study 9662077 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 45 minutes
Number of subjects: 0
Study 9662077 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenal lipid (Intralipid 20%) infusion for 15 minutes
Number of subjects: 0
Study 9662077 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 0
Study 2709366 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger-floss
Number of subjects: 112
Study 2709366 — intervention group
Group type: COMPARATOR
Intervention: Brushing-only
Number of subjects: 112
Study 2709366 — intervention group
Group type: EXPERIMENTAL
Intervention: Looped-floss
Number of subjects: 112
Study 2709366 — intervention group
Group type: EXPERIMENTAL
Intervention: Flossholder
Number of subjects: 112
Study 1257500 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 4
Study 1257500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 31078427 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) for CTO in symptomatic patients
Number of subjects: 0
Study 31078427 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study 27922026 — intervention group
Group type: EXPERIMENTAL
Intervention: AspireAssist plus Lifestyle Counseling
Number of subjects: 207
Study 27922026 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle Counseling alone
Number of subjects: 207
Study 26408513 — intervention group
Group type: COMPARATOR
Intervention: Controlled Breathing (CB)
Number of subjects: 82
Study 26408513 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Breathing with Aromatherapy (IPA)
Number of subjects: 82
Study 23159721 — intervention group
Group type: EXPERIMENTAL
Intervention: High load (20 sets of 2 repetitions)
Number of subjects: 32
Study 23159721 — intervention group
Group type: EXPERIMENTAL
Intervention: Low load (2 sets of 20 repetitions)
Number of subjects: 32
Study 23159721 — intervention group
Group type: COMPARATOR
Intervention: Combined (low and high load)
Number of subjects: 32
Study 21288364 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (CC)
Number of subjects: 40
Study 21288364 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (DC)
Number of subjects: 40
Study 21288364 — intervention group
Group type: COMPARATOR
Intervention: Control (no coffee)
Number of subjects: 40
Study 19392864 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 30 mg
Number of subjects: 947
Study 19392864 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexlansoprazole MR 60 mg
Number of subjects: 947
Study 19392864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 947
Study 16938693 — intervention group
Group type: EXPERIMENTAL
Intervention: STM tasks
Number of subjects: 403
Study 16938693 — intervention group
Group type: EXPERIMENTAL
Intervention: WM tasks
Number of subjects: 403
Study 15707175 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial screening program using faecal occult blood tests
Number of subjects: 0
Study 15707175 — intervention group
Group type: EXPERIMENTAL
Intervention: Extending the program to include 70 to 74-year-olds
Number of subjects: 0
Study 11570305 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy with low-dose acetylsalicylic acid (ASA) initiated within 48 hours of stroke onset
Number of subjects: 0
Study 11570305 — intervention group
Group type: EXPERIMENTAL
Intervention: Dedicated care for stroke patients
Number of subjects: 0
Study 11570305 — intervention group
Group type: EXPERIMENTAL
Intervention: Research into defibrinogenating and neuroprotective agents
Number of subjects: 0
Study 11570305 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 0
Study 11570305 — intervention group
Group type: COMPARATOR
Intervention: Routine anticoagulation
Number of subjects: 0
Study 9250108 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-2% acetylated potato starch
Number of subjects: 11
Study 9250108 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% beta-cyclodextrin starch
Number of subjects: 11
Study 9250108 — intervention group
Group type: COMPARATOR
Intervention: Control (native, unmodified potato starch)
Number of subjects: 11
Study 8323207 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluids ad libitum from the first postoperative day (group 1)
Number of subjects: 60
Study 8323207 — intervention group
Group type: COMPARATOR
Intervention: Traditional graduated regimen of 30 ml/h for 24 h, 60 ml/h for 24 h, 90 ml/h for 24 h, then free fluids (group 2)
Number of subjects: 60
Study 3609882 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine (5-10 mg/day, orally in drops)
Number of subjects: 14
Study 3609882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30284589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand hygiene workshop intervention
Number of subjects: 496
Study 30284589 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 496
Study 26861469 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 0.3 mg/kg
Number of subjects: 146
Study 26861469 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 2.0 mg/kg
Number of subjects: 146
Study 26861469 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 10.0 mg/kg
Number of subjects: 146
Study 26861469 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (all doses)
Number of subjects: 146
Study 24157251 — intervention group
Group type: EXPERIMENTAL
Intervention: Meridian-marking method
Number of subjects: 0
Study 24157251 — intervention group
Group type: COMPARATOR
Intervention: Surgeon's intuition method
Number of subjects: 0
Study 24157251 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 22522344 — intervention group
Group type: EXPERIMENTAL
Intervention: Mere15 polypeptide
Number of subjects: 1
Study 22434968 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga exercise for 50 minutes daily for 4 weeks
Number of subjects: 24
Study 22434968 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 24
Study 18765391 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine
Number of subjects: 19
Study 18765391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 15925132 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for body image concerns
Number of subjects: 41
Study 15925132 — intervention group
Group type: COMPARATOR
Intervention: Weight management group
Number of subjects: 41
Study 12772232 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic-coated sheath
Number of subjects: 90
Study 12772232 — intervention group
Group type: COMPARATOR
Intervention: Uncoated sheath
Number of subjects: 90
Study 10468724 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of transurethral thermotherapy (TUMT)
Number of subjects: 44
Study 10468724 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 min of transurethral thermotherapy (TUMT)
Number of subjects: 44
Study 10468724 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 44
Study 8983255 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin
Number of subjects: 442
Study 8983255 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 442
Study 2006936 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant‐TA (modified bovine surfactant extract)
Number of subjects: 41
Study 2006936 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 41
Study 2006936 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Surfactant‐TA and Saline)
Number of subjects: 41
Study 7102445 — intervention group
Group type: EXPERIMENTAL
Intervention: Preparation stage
Number of subjects: 73
Study 7102445 — intervention group
Group type: EXPERIMENTAL
Intervention: Aversion stage
Number of subjects: 73
Study 7102445 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance stage
Number of subjects: 73
Study 7102445 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of stages
Number of subjects: 73
Study 7102445 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster sessions
Number of subjects: 73
Study 7102445 — intervention group
Group type: COMPARATOR
Intervention: All conditions
Number of subjects: 73
Study 7102445 — intervention group
Group type: COMPARATOR
Intervention: Follow-up at 12 months
Number of subjects: 73
Study 31688081 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese/OSAS group
Number of subjects: 34
Study 31688081 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonobese/OSAS and Obese/OSAS groups
Number of subjects: 34
Study 30876470 — intervention group
Group type: EXPERIMENTAL
Intervention: 180-s exposure to partial-body cryostimulation after training
Number of subjects: 9
Study 30876470 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no cryostimulation)
Number of subjects: 9
Study 30876470 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 90-s exposures separated by a 5-min rest at room temperature
Number of subjects: 9
Study 30876470 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-s exposure
Number of subjects: 9
Study 28364452 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 60
Study 27688021 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured group psychoeducation
Number of subjects: 304
Study 27688021 — intervention group
Group type: COMPARATOR
Intervention: Optimised unstructured peer support
Number of subjects: 304
Study 24572139 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and education
Number of subjects: 98
Study 24572139 — intervention group
Group type: COMPARATOR
Intervention: Education only
Number of subjects: 98
Study 22686415 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (1-g capsule containing at least 900 mg of ethyl esters of n-3 fatty acids daily)
Number of subjects: 12536
Study 19478198 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin 2.5 mg plus metformin
Number of subjects: 743
Study 19478198 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin 5 mg plus metformin
Number of subjects: 743
Study 19478198 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin 10 mg plus metformin
Number of subjects: 743
Study 19478198 — intervention group
Group type: EXPERIMENTAL
Intervention: Saxagliptin (2.5, 5, and 10 mg) plus metformin
Number of subjects: 743
Study 19478198 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus metformin
Number of subjects: 743
Study 17192326 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced therapy (infrared skin thermometer to measure temperatures on six foot sites daily)
Number of subjects: 173
Study 17192326 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (therapeutic footwear, diabetic foot education, regular foot care)
Number of subjects: 173
Study 17192326 — intervention group
Group type: COMPARATOR
Intervention: Structured foot examination (daily structured foot inspection and logbook)
Number of subjects: 173
Study 15193553 — intervention group
Group type: EXPERIMENTAL
Intervention: Damped DILE (dynamic impact-loading exercise)
Number of subjects: 24